Radiopharmaceuticals Market Research Report by Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), by Procedural Volume (Diagnostic Procedures and Therapeutic Procedures), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Radiopharmaceuticals Market is expected to grow from USD 4,314.59 Million in 2020 to USD 5,616.32 Million by the end of 2025.
2. The Global Radiopharmaceuticals Market is expected to grow from EUR 3,783.11 Million in 2020 to EUR 4,924.49 Million by the end of 2025.
3. The Global Radiopharmaceuticals Market is expected to grow from GBP 3,363.19 Million in 2020 to GBP 4,377.88 Million by the end of 2025.
4. The Global Radiopharmaceuticals Market is expected to grow from JPY 460,476.25 Million in 2020 to JPY 599,403.93 Million by the end of 2025.
5. The Global Radiopharmaceuticals Market is expected to grow from AUD 6,265.36 Million in 2020 to AUD 8,155.64 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Radiopharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Radiopharmaceuticals Market studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Nuclear Medicine further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.
Based on Procedural Volume, the Radiopharmaceuticals Market studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Procedures further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.
Based on Application, the Radiopharmaceuticals Market studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications further studied across Pet Applications and Spect Applications. The Therapeutic Applications further studied across Bone Metastasis, Endocrine Tumors, Lymphoma, and Thyroid.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Radiopharmaceuticals Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Radiopharmaceuticals Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Radiopharmaceuticals Market including Advanced Accelerator Applications S.A, Alliance Medical, Bayer AG, Bracco Imaging SpA, Cardinal Health, Inc., Clarity Pharmaceuticals, Curium France SASU, Eckert & Ziegler, Eczacibasi-Monrol Nuclear Products Co., Fusion Pharma, GE Healthcare Inc, Global Medical Solutions, LTD., Institute of Isotopes Co., LTD., IsoTherapeutics Group, LLC, Isotopia Molecular Imaging Limited, Joint Stock Company Isotope, Jubilant Pharma Holdings Inc., Lantheus Medical Imaging, Inc., Mallinckrodt PLC, Medtronic PLC, Navidea Biopharmaceuticals, Inc., Nordion, Inc., Northstar Medical Radioisotopes, LLC, NTP Radioisotopes Soc, LTD., Pharmalogic, Shine Medical Technologies, Siemens Healthineers AG, Sigma- Aldrich Corporation, and Sinotau Pharmaceuticals Group.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Radiopharmaceuticals Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Radiopharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Radiopharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Radiopharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Radiopharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Radiopharmaceuticals Market?
6. What are the modes and strategic moves considered suitable for entering the Global Radiopharmaceuticals Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Radiopharmaceuticals Market is expected to grow from USD 4,314.59 Million in 2020 to USD 5,616.32 Million by the end of 2025.
2. The Global Radiopharmaceuticals Market is expected to grow from EUR 3,783.11 Million in 2020 to EUR 4,924.49 Million by the end of 2025.
3. The Global Radiopharmaceuticals Market is expected to grow from GBP 3,363.19 Million in 2020 to GBP 4,377.88 Million by the end of 2025.
4. The Global Radiopharmaceuticals Market is expected to grow from JPY 460,476.25 Million in 2020 to JPY 599,403.93 Million by the end of 2025.
5. The Global Radiopharmaceuticals Market is expected to grow from AUD 6,265.36 Million in 2020 to AUD 8,155.64 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Radiopharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the Radiopharmaceuticals Market studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Nuclear Medicine further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.
Based on Procedural Volume, the Radiopharmaceuticals Market studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Procedures further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.
Based on Application, the Radiopharmaceuticals Market studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications further studied across Pet Applications and Spect Applications. The Therapeutic Applications further studied across Bone Metastasis, Endocrine Tumors, Lymphoma, and Thyroid.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Radiopharmaceuticals Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Radiopharmaceuticals Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Radiopharmaceuticals Market including Advanced Accelerator Applications S.A, Alliance Medical, Bayer AG, Bracco Imaging SpA, Cardinal Health, Inc., Clarity Pharmaceuticals, Curium France SASU, Eckert & Ziegler, Eczacibasi-Monrol Nuclear Products Co., Fusion Pharma, GE Healthcare Inc, Global Medical Solutions, LTD., Institute of Isotopes Co., LTD., IsoTherapeutics Group, LLC, Isotopia Molecular Imaging Limited, Joint Stock Company Isotope, Jubilant Pharma Holdings Inc., Lantheus Medical Imaging, Inc., Mallinckrodt PLC, Medtronic PLC, Navidea Biopharmaceuticals, Inc., Nordion, Inc., Northstar Medical Radioisotopes, LLC, NTP Radioisotopes Soc, LTD., Pharmalogic, Shine Medical Technologies, Siemens Healthineers AG, Sigma- Aldrich Corporation, and Sinotau Pharmaceuticals Group.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Radiopharmaceuticals Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Radiopharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Radiopharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Radiopharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Radiopharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Radiopharmaceuticals Market?
6. What are the modes and strategic moves considered suitable for entering the Global Radiopharmaceuticals Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. Procedural Volume Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence and prevalence of target conditions
5.1.1.2. Alpha radioimmunotherapy-based targeted cancer treatment
5.1.1.3. Initiatives to reduce the demand-supply gap of mo-99
5.1.2. Restraints
5.1.2.1. Shorter life of radiopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Adoption of radiopharmaceuticals in neurological applications
5.1.4. Challenges
5.1.4.1. High equipment prices lead to reduced hospital budget
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Introduction
6.2. Diagnostic Nuclear Medicine
6.2.1. Pet Radiopharmaceuticals
6.2.1.1. F-18
6.2.1.2. Ru-82
6.2.2. Spect Radiopharmaceuticals
6.2.2.1. Ga-67
6.2.2.2. I-123
6.2.2.3. Tc-99m
6.2.2.4. Tl-201
6.3. Therapeutic Nuclear Medicine
6.3.1. Alpha Emitters
6.3.1.1. Ra-223
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-177
6.3.2.3. Re-186
6.3.2.4. Sm-153
6.3.2.5. Y-90
6.3.3. Brachytherapy Isotopes
6.3.3.1. Cs-131
6.3.3.2. I-125
6.3.3.3. Ir-192
6.3.3.4. Pd-103
7. GLOBAL RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUME
7.1. Introduction
7.2. Diagnostic Procedures
7.2.1. Pet Radiopharmaceuticals
7.2.2. Spect Radiopharmaceuticals
7.3. Therapeutic Procedures
7.3.1. Alpha Emitters
7.3.2. Beta Emitters
7.3.3. Brachytherapy Isotopes
8. GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION
8.1. Introduction
8.2. Diagnostic Applications
8.2.1. Pet Applications
8.2.1.1. Cardiology
8.2.1.2. Neurology
8.2.1.3. Oncology
8.2.2. Spect Applications
8.2.2.1. Cardiology
8.2.2.2. Lymphoma
8.2.2.3. Neurology
8.2.2.4. Thyroid
8.3. Therapeutic Applications
8.3.1. Bone Metastasis
8.3.2. Endocrine Tumors
8.3.3. Lymphoma
8.3.4. Thyroid
9. AMERICAS RADIOPHARMACEUTICALS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Advanced Accelerator Applications S.A
13.2. Alliance Medical
13.3. Bayer AG
13.4. Bracco Imaging SpA
13.5. Cardinal Health, Inc.
13.6. Clarity Pharmaceuticals
13.7. Curium France SASU
13.8. Eckert & Ziegler
13.9. Eczacibasi-Monrol Nuclear Products Co.
13.10. Fusion Pharma
13.11. GE Healthcare Inc
13.12. Global Medical Solutions, LTD.
13.13. Institute of Isotopes Co., LTD.
13.14. IsoTherapeutics Group, LLC
13.15. Isotopia Molecular Imaging Limited
13.16. Joint Stock Company Isotope
13.17. Jubilant Pharma Holdings Inc.
13.18. Lantheus Medical Imaging, Inc.
13.19. Mallinckrodt PLC
13.20. Medtronic PLC
13.21. Navidea Biopharmaceuticals, Inc.
13.22. Nordion, Inc.
13.23. Northstar Medical Radioisotopes, LLC
13.24. NTP Radioisotopes Soc, LTD.
13.25. Pharmalogic
13.26. Shine Medical Technologies
13.27. Siemens Healthineers AG
13.28. Sigma- Aldrich Corporation
13.29. Sinotau Pharmaceuticals Group
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. Procedural Volume Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence and prevalence of target conditions
5.1.1.2. Alpha radioimmunotherapy-based targeted cancer treatment
5.1.1.3. Initiatives to reduce the demand-supply gap of mo-99
5.1.2. Restraints
5.1.2.1. Shorter life of radiopharmaceuticals
5.1.3. Opportunities
5.1.3.1. Adoption of radiopharmaceuticals in neurological applications
5.1.4. Challenges
5.1.4.1. High equipment prices lead to reduced hospital budget
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Introduction
6.2. Diagnostic Nuclear Medicine
6.2.1. Pet Radiopharmaceuticals
6.2.1.1. F-18
6.2.1.2. Ru-82
6.2.2. Spect Radiopharmaceuticals
6.2.2.1. Ga-67
6.2.2.2. I-123
6.2.2.3. Tc-99m
6.2.2.4. Tl-201
6.3. Therapeutic Nuclear Medicine
6.3.1. Alpha Emitters
6.3.1.1. Ra-223
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-177
6.3.2.3. Re-186
6.3.2.4. Sm-153
6.3.2.5. Y-90
6.3.3. Brachytherapy Isotopes
6.3.3.1. Cs-131
6.3.3.2. I-125
6.3.3.3. Ir-192
6.3.3.4. Pd-103
7. GLOBAL RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUME
7.1. Introduction
7.2. Diagnostic Procedures
7.2.1. Pet Radiopharmaceuticals
7.2.2. Spect Radiopharmaceuticals
7.3. Therapeutic Procedures
7.3.1. Alpha Emitters
7.3.2. Beta Emitters
7.3.3. Brachytherapy Isotopes
8. GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION
8.1. Introduction
8.2. Diagnostic Applications
8.2.1. Pet Applications
8.2.1.1. Cardiology
8.2.1.2. Neurology
8.2.1.3. Oncology
8.2.2. Spect Applications
8.2.2.1. Cardiology
8.2.2.2. Lymphoma
8.2.2.3. Neurology
8.2.2.4. Thyroid
8.3. Therapeutic Applications
8.3.1. Bone Metastasis
8.3.2. Endocrine Tumors
8.3.3. Lymphoma
8.3.4. Thyroid
9. AMERICAS RADIOPHARMACEUTICALS MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Advanced Accelerator Applications S.A
13.2. Alliance Medical
13.3. Bayer AG
13.4. Bracco Imaging SpA
13.5. Cardinal Health, Inc.
13.6. Clarity Pharmaceuticals
13.7. Curium France SASU
13.8. Eckert & Ziegler
13.9. Eczacibasi-Monrol Nuclear Products Co.
13.10. Fusion Pharma
13.11. GE Healthcare Inc
13.12. Global Medical Solutions, LTD.
13.13. Institute of Isotopes Co., LTD.
13.14. IsoTherapeutics Group, LLC
13.15. Isotopia Molecular Imaging Limited
13.16. Joint Stock Company Isotope
13.17. Jubilant Pharma Holdings Inc.
13.18. Lantheus Medical Imaging, Inc.
13.19. Mallinckrodt PLC
13.20. Medtronic PLC
13.21. Navidea Biopharmaceuticals, Inc.
13.22. Nordion, Inc.
13.23. Northstar Medical Radioisotopes, LLC
13.24. NTP Radioisotopes Soc, LTD.
13.25. Pharmalogic
13.26. Shine Medical Technologies
13.27. Siemens Healthineers AG
13.28. Sigma- Aldrich Corporation
13.29. Sinotau Pharmaceuticals Group
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. GLOBAL RADIOPHARMACEUTICALS MARKET: SCORES
TABLE 140. GLOBAL RADIOPHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 141. GLOBAL RADIOPHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 142. GLOBAL RADIOPHARMACEUTICALS MARKET: RANKING
TABLE 143. GLOBAL RADIOPHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 144. GLOBAL RADIOPHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 145. GLOBAL RADIOPHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 146. GLOBAL RADIOPHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 147. GLOBAL RADIOPHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 148. GLOBAL RADIOPHARMACEUTICALS MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 138. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 139. GLOBAL RADIOPHARMACEUTICALS MARKET: SCORES
TABLE 140. GLOBAL RADIOPHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 141. GLOBAL RADIOPHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 142. GLOBAL RADIOPHARMACEUTICALS MARKET: RANKING
TABLE 143. GLOBAL RADIOPHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 144. GLOBAL RADIOPHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 145. GLOBAL RADIOPHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 146. GLOBAL RADIOPHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 147. GLOBAL RADIOPHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 148. GLOBAL RADIOPHARMACEUTICALS MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL RADIOPHARMACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RADIOPHARMACEUTICALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 (USD MILLION)
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL RADIOPHARMACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2025 (%)
FIGURE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2025
FIGURE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025
FIGURE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 57. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2020 VS 2025 (USD MILLION)
FIGURE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2020 VS 2025 (USD MILLION)
FIGURE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, 2020 VS 2025 (USD MILLION)
FIGURE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, 2020 VS 2025 (USD MILLION)
FIGURE 66. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2020 VS 2025 (USD MILLION)
FIGURE 67. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2020 VS 2025 (USD MILLION)
FIGURE 68. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 69. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 70. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 71. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 77. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 79. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 87. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 88. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 89. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 90. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 91. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 92. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 93. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 94. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 95. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 96. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 97. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 98. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 99. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 100. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 101. UNITED K
FIGURE 1. GLOBAL RADIOPHARMACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RADIOPHARMACEUTICALS MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 (USD MILLION)
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL RADIOPHARMACEUTICALS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
FIGURE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2025
FIGURE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2020 VS 2025 (USD MILLION)
FIGURE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, 2020 VS 2025 (USD MILLION)
FIGURE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2025 (%)
FIGURE 41. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2025
FIGURE 43. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2020 VS 2025 (USD MILLION)
FIGURE 44. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 45. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2020 VS 2025 (USD MILLION)
FIGURE 46. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2020 VS 2025 (USD MILLION)
FIGURE 47. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 48. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2020 VS 2025 (USD MILLION)
FIGURE 49. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2020 VS 2025 (USD MILLION)
FIGURE 50. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 51. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025
FIGURE 53. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 54. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 55. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 56. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 57. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 58. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 59. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 60. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2020 VS 2025 (USD MILLION)
FIGURE 61. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2020 VS 2025 (USD MILLION)
FIGURE 62. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2020 VS 2025 (USD MILLION)
FIGURE 63. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 64. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, 2020 VS 2025 (USD MILLION)
FIGURE 65. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, 2020 VS 2025 (USD MILLION)
FIGURE 66. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2020 VS 2025 (USD MILLION)
FIGURE 67. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2020 VS 2025 (USD MILLION)
FIGURE 68. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 69. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 70. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 71. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 76. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 77. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 78. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 79. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 80. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 81. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 82. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 83. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 84. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 85. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 86. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 87. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 88. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 89. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 90. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 91. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 92. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 93. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 94. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 95. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 96. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 97. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 98. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 99. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 100. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 101. UNITED K
